Kilitch Drugs | Balance Sheet

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
830
296
259
251
356
364
Total Accounts Receivable
86
126
164
151
207
194
Inventories
29
29
26
26
28
47
Other Current Assets
13
16
23
30
38
44
Total Current Assets
959
467
473
458
630
649
Net Property, Plant & Equipment
93
93
87
87
110
288
Total Investments and Advances
12
472
258
268
268
250
Long-Term Note Receivable
-
-
-
-
2
-
Intangible Assets
-
1
337
253
252
236
Other Assets
227
230
3
1
-
3
Total Assets
1,291
1,267
1,167
1,082
1,277
1,437
ST Debt & Current Portion LT Debt
-
-
2
7
9
Accounts Payable
47
24
43
57
77
Income Tax Payable
-
-
-
1
20
Other Current Liabilities
39
44
35
40
43
Total Current Liabilities
87
69
80
104
149
Deferred Taxes
2
5
9
15
16
Total Liabilities
88
69
80
104
149
Common Equity (Total)
1,202
1,199
1,087
978
1,120
Total Shareholders' Equity
1,202
1,199
1,087
978
1,120
Total Equity
1,202
1,199
1,087
978
1,128
Liabilities & Shareholders' Equity
1,291
1,267
1,167
1,082
1,277
Accumulated Minority Interest
-
-
-
-
7

About Kilitch Drugs

View Profile
Address
Ujagar Industrial Estate
Mumbai Maharashtra 400088
India
Employees -
Website http://www.kilitch.com
Updated 07/08/2019
Kilitch Drugs (India) Ltd. engages in the provision of pharmaceutical solutions. Its products include parenterals and nasal, oral, effervescent, nutritional, medical device, cosmetics, and herbal. The company was founded by Pratap Keshavji Mehta in 1978 and is headquartered in Mumbai, India.